secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2022-07-12T23:59:59+00:00
Accession:  0001193125-22-191783
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences adopts poison pill rights plan with 10% trigger
-----------------------------------------------------------------

- Board declares dividend of one Right per share of common stock; record date July 21, 2022.
- Rights exercisable at $16 per one thousandth of Series A Participating Preferred share.
- Rights become exercisable if a person acquires 10% (20% for certain institutional holders) of common stock.
- Rights expire on July 12, 2023, redeemable at $0.001 per Right at board's option.
- Certificate of Designation for Series A Preferred filed with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312522191783/0001193125-22-191783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312522191783/d598392d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-191783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer